Also found in: Medical.
CERADConsortium to Establish A Registry for Alzheimer's Disease
CERADCentral European Weather Radar Network
References in periodicals archive ?
EXAMPLE 4, SAMPLE AUTOPSY SIGNOUT: * Frontotemporal lobar degeneration with TDP-43 pathology (FTLD-TDP), Type A, with: *** Severe temporal lobe atrophy, bilateral *** Frontal lobe atrophy, mild *** Hippocampal sclerosis, bilateral, severe *** Neuronal intranuclear ("lentiform") inclusions * Alzheimer disease neuropathology changes, "high", (A2,B3,C1): *** Thal phase for amyloid plaques: 3 (A2) *** Braak and Braak neurofibrillary stage: V (B3) *** CERAD neuritic plaque score: Predominantly sparse (CI) *** No cerebral amyloid angiopathy is identified * No Lewy body disease pathology is identified Comment: FTLD-TDP, Type A, is identified with associated severe TDP-43 proteinopathy, circumscribed atrophy of bilateral anteromedial temporal lobes and bilateral hippocampal sclerosis.
The CERAD neuropsychological test battery is widely used in the early detection of Alzheimer's disease.
In a multivariate analysis, deficits on CERAD Recognition Memory and Trail Making B were associated with a 6.
2010) Total scores of the CERAD neuropsychological assessment battery: validation for mild cognitive impairment and dementia patients with diverse etiologies.
4 These criteria essentially encompass both CERAD and Braak criteria (Table 3).
Se llevo a cabo un analisis de regresion logistica para determinar la contribucion de las variables del CERAD para la pertenecia a un grupo diagnostico, considerando la edad, sexo y gravedad de la enfermedad como covariables.
Detection of abnormal memory decline in mild cases of Alzheimer's disease using CERAD neuropsychological measures.
A 15-item version of the test is used in the CERAD battery.
The experiences of the CERAD show positive responses to research when community members are included on advisory panels and incentives are offered to study participants.
The CERAD stated that more sensible techniques were needed when measuring global atrophy.
This test battery includes the Mini-Mental State Examination (MMSE) [24], a 10-item word list learning, recall and recognition task, a measure of verbal fluency, confrontation naming (abbreviated 15-item Boston naming test) and a constructional praxis task, the clock drawing test, which is part of the CERAD clinical battery [23] was also included.